The Arbutus Innovation Centre is a work hub, incubator, and research centre located in Athlone, Co Roscommon.

Client and partner access to state-of-the-art pharmaceutical facilities that support European research, intellectual property development, product registration and turnkey manufacturing solutions for medicines, cosmetics, medical devices and other products.

A gateway to Europe for multi-nationals, the AIC fosters pharmaceutical and biotechnology innovation all the way from early stage research up to full commercialisation.

Supports and facilities for companies in niche and nascent industries to learn small, learn fast and learn thoroughly to make informed business and production decisions effectively and efficiently.

Streamlined and simplified market entry into new emerging markets. The AIC team of experienced professionals have backgrounds in compliance, production, business and finance for the regulated pharmaceutical, cosmeceutical and food industries.

The Arbutus Innovation Centre is here to help you succeed.

Our Innovation Centre is agile and adaptable, designed to service both pharmaceutical and non-pharmaceutical operations.

We facilitate collaboration between industry, top universities and other stakeholders with our cutting-edge research infrastructure and cross-sector industry knowledge.

“We appreciate the importance of major pharmaceutical, economic and healthcare trends in Europe. Through this unwavering appreciation, we invested in a high spec pharmaceutical facility, careful product planning and targeted research. We carefully consider existing regulatory frameworks, upcoming policy changes and market demand when making strategic business decisions.

Recent global events and trends, both political and environmental, will compound the challenges the pharmaceutical industry face, but they will also provide major opportunities. These opportunities present themselves to those of us who are willing to bridge the gap between true sustainability, conscious business practices, product transparency and pharmaceutical licensing.”

Leah Fletcher, Founder

•  New product marketing authorization license applications within the EU

• Product claim support

• Product variations and renewals

• Transfers and withdrawals

• Regulatory guidelines related to procedural and regulatory requirements within the European Medicines Agency

• Traditional Medicines (2004/24/EC)

• Cosmetics ((EC) No. 1223/2009)

• Product information files

• Product conformity

• Non-compliance protocols

• Traceability procedures

• Risk assessment

Manufacturing

• Pharmaceutical clean rooms

• Biomass extraction capacity up to 450,000 kg

• Distillation and isolation of compounds

• Pharmaceutical grade production standards

• GMP Compliant Clean Rooms

• Versatile Work-Flows, in-take areas, HVAC system

• Warehousing Area

• Quarantine & Cleaning areas